On June 4, the FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults.
Read more at fda.gov.
Δ
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
Notifications
